Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib Long-term Treatment Extension in Ph+ CML (China Cohort)
CTR20150172Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bosutinib in chronic myelogenous leukemia (CML), sponsored by Pfizer. Started Jun 2021; status: completed.
02
Drugs
bosutinib
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on CTR20150172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150172.